What Researchers Did
Researchers measured transcutaneous oxygen pressure (Ptco2) in edematous wounds of patients before and after hyperbaric oxygen (HBO2) therapy, under various oxygen conditions.
What They Found
Before therapy, Ptco2 in markedly edematous wounds was significantly lower than in less edematous wounds when breathing air (P < 0.001). After hyperbaric oxygen therapy, wound severity and periwound edema ratings significantly decreased (P < 0.001), and Ptco2 dramatically increased in hypoxic edematous wounds during oxygen challenges (P < 0.0001).
What This Means for Canadian Patients
Canadian patients with edematous wounds, particularly those with marked edema, may benefit from hyperbaric oxygen therapy to reduce swelling and improve oxygen delivery to the affected tissues. This treatment could potentially accelerate wound healing and improve overall outcomes for complex or non-healing wounds.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
Despite significant correlations, single Ptco2 measurements were not found to be predictive of changes in periwound edema or overall wound severity.